Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.26 AUD | +4.00% | -1.89% | -23.53% |
03/05 | Transcript : Next Science Limited - Shareholder/Analyst Call | |
24/04 | Next Science Product Sales Rise 19% to $5.5 Million for March Quarter | MT |
Sales 2024 * | 32.71M 49.17M 2.73B | Sales 2025 * | 40.67M 61.14M 3.39B | Capitalization | 50.36M 75.7M 4.2B |
---|---|---|---|---|---|
Net income 2024 * | -13M -19.54M -1.08B | Net income 2025 * | -8M -12.03M -667M | EV / Sales 2024 * | 1.15 x |
Net cash position 2024 * | 12.75M 19.17M 1.06B | Net cash position 2025 * | 5.02M 7.54M 419M | EV / Sales 2025 * | 1.11 x |
P/E ratio 2024 * |
-3.53
x | P/E ratio 2025 * |
-8.41
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 46.65% |
Latest transcript on Next Science Limited
1 day | +4.00% | ||
1 week | -1.89% | ||
1 month | -16.13% | ||
3 months | -17.46% | ||
6 months | +8.33% | ||
Current year | -23.53% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Myntti
FOU | Founder | - | 20/17/20 |
Harry Hall
CEO | Chief Executive Officer | - | 10/23/10 |
Marc Zimmerman
DFI | Director of Finance/CFO | - | 26/23/26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Harry Hall
CEO | Chief Executive Officer | - | 10/23/10 |
Grant Hummel
BRD | Director/Board Member | - | 23/23/23 |
Chairman | 62 | 01/18/01 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 0.26 | +4.00% | 63,536 |
30/24/30 | 0.25 | -1.96% | 18,918 |
29/24/29 | 0.255 | -3.77% | 151,381 |
28/24/28 | 0.265 | -1.85% | 85,802 |
27/24/27 | 0.27 | +1.89% | 75,977 |
Delayed Quote Australian S.E., May 31, 2024 at 11:40 am IST
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.53% | 50.36M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- NXS Stock